Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Chaim Lebovits Insider Profile
11 Followers
Chaim Lebovits, President & CEO at Brainstorm Cell Therapeutics, holds 214.35K shares in Brainstorm Cell Therapeutics (Ticker: BCLI). Most recently, Chaim Lebovits Bought $23,836 shares of Brainstorm Cell Therapeutics on Oct 02, 2024 for an estimated value of 11.12K.
Chaim Lebovits has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
President & CEO
Roles that Chaim Lebovits holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Oct 02, 2024 - Today
Return:-39.70%
The most profitable trade made by Chaim Lebovits
Chaim Lebovits's Trading History
List of latest transactions for each holding click on a transaction to see Chaim Lebovits's performance on stock
You May Also Like
Chaim Lebovits insider profile FAQ
What is the percentage of profitable transactions made by Chaim Lebovits?
The percentage of profitable transactions made by Chaim Lebovits is ―.
What is the average return per transaction made by Chaim Lebovits?
The average return per transaction made by Chaim Lebovits is ―.
What stocks does Chaim Lebovits hold?
Chaim Lebovits holds: BCLI stocks.
What was Chaim Lebovits’s latest transaction?
Chaim Lebovits latest transaction was an Informative Buy of $11.12K.
What was Chaim Lebovits's most profitable transaction?
Chaim Lebovits’s most profitable transaction was an Informative Buy of BCLI stock on October 2, 2024. The return on the trade was -39.70%.
What is Chaim Lebovits's role in Brainstorm Cell Therapeutics?
Chaim Lebovits's role in Brainstorm Cell Therapeutics is President & CEO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.